%0 Journal Article %A Zachary J. Madewell %A Kelly Charniga %A Nina B. Masters %A Jason Asher %A Lily Fahrenwald %A William Still %A Judy Chen %A Naama Kipperman %A David Bui %A Meghan Shea %A Lori Saathoff-Huber %A Shannon Johnson %A Khalil Harbi %A Abby L. Berns %A Taidy Perez %A Emily Gateley %A Ian H. Spicknall %A Yoshinori Nakazawa %A Thomas L. Gift %A 2022 Monkeypox Outbreak Response Team %T Serial interval and incubation period estimates of monkeypox virus infection in 12 U.S. jurisdictions, May – August 2022 %D 2022 %R 10.1101/2022.10.26.22281516 %J medRxiv %P 2022.10.26.22281516 %X Using data collected by 12 U.S. health departments, we report mean estimated serial interval for monkeypox virus infection of 8.5 (95% CrI: 7.3 – 9.9) days for symptom onset from 57 case pairs and mean estimated incubation period of 5.6 (4.3 – 7.8) days from 35 case pairs for symptom onset.One sentence summary We report the mean estimated serial interval for monkeypox virus infection of 8.5 (95% CrI: 7.3 – 9.9) days for symptom onset from 57 case pairs and mean estimated incubation period of 5.6 (4.3 – 7.8) days from 35 case pairs for symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the U.S. Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy (45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. %U https://www.medrxiv.org/content/medrxiv/early/2022/10/30/2022.10.26.22281516.full.pdf